Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Medical Second Opinion Market – Comprehensive Study Report with Recent Trends 2024-2032
The Medical Second Opinion Market as defined in this research is the industry that deals with offering consultation services beyond the initial encounters that involve referrals to healthcare professionals with expertise in diagnosis and treatment of certain conditions or diseases.
IMR Group
Description
Medical Second Opinion Market Synopsis:
Medical Second Opinion Market Size Was Valued at USD 6.7 Billion in 2023, and is Projected to Reach USD 26.49 Billion by 2032, Growing at a CAGR of 16.5% From 2024-2032.
The Medical Second Opinion Market as defined in this research is the industry that deals with offering consultation services beyond the initial encounters that involve referrals to healthcare professionals with expertise in diagnosis and treatment of certain conditions or diseases. They can use this market to find other opinions for a confirmed disease or treatment options, as well as obtain more information about the disease or condition in aggravated cases. Telemedicine and digital health platforms enabling the delivery of second medical opinions have grown in the global market helping patient-champions to support them in decision-making processes for their treatment.
The Medical Second Opinion Market globally has been growing rapidly due to increasing patient interest towards asking another opinion for key clinical conditions. The use of teleconsultations from specialists across the world presents an advancement of the market after the development of digital health innovations. Consequently, there is a constant and constant increase in second opinions for cancers, cardiac ailments, neurological diseases, and nearly all forms of chronic illness in patients. Already, numerous hospitals, insurance organizations, and specialty clinics are partnering with second-opinion service providers who are ready to offer an extensive package to clients.
Additionally, markets are global and benefit from the rising aging population for the world, North America and Europe in particular where per capital health care is relatively expensive. Key drivers of growth in this market include the transfer to value based care model and increasing emphasis on individualized medicine. Other than serving the patient’s interested, most medical second opinions avert wrong diagnoses thus minimizing unnecessary medical expenses. Growing public awareness for health management and self-ossification is driving a higher uptake for the second opinion service, making this a viable market in today’s societies.
Medical Second Opinion Market Trend Analysis:
Increasing Digital Access to Second Opinions Boosting the Market
Incorporation of the telemedicine platforms in the ongoing improvement of the various digital health technologies has seen the Medical Second Opinion Market experience a massive boost. Patients in rural areas and those who experience difficulties affirmatively improved mobility because the availability of higher quality doctors and specialists from other countries is easier now with improved connection to the Internet. This greater digital coverage is not only helping to satisfy the demands of an educated patient-consumer base, but also in terms of time and expense on the part of patients. That is why, thanks to the availability and benefits of digital health, the Medical Second Opinion Market has become a vital key in the development of the future health care system.
Emerging Opportunities in Cancer Care for Medical Second Opinions
Out of all fields, cancer treatments and medical second opinions are indispensable in the cancer niche. As more different kinds of treatment are available for cancer, and as many cancer diagnoses are less easily categorized, patients turn to second opinions as a new avenue. Other segments that continue to be popular are those in personalized medicine and oncology, where patients want confirmation of their treatment options, familiarise themselves with new treatments, or get explanations for difficult diagnoses. The Medical Second Opinion Market is embarking on a mission of becoming a supporting framework for the reasoning and selection making of cancer patients so they can easily select the correct and best treatment, thereby leading to better treatment outcomes for them.
Medical Second Opinion Market Segment Analysis:
Medical Second Opinion Market is Segmented on the basis of Condition, Service Providers, and Region.
By Condition, Cancer segment is expected to dominate the market during the forecast period
Cancer segment is also expected to have a large share in Medical Second Opinion Market throughout the forecast period. Cancer is increasing in incidence almost all over the world and with this increase patients are getting more vigilant and selective in ascertaining their ailment and seeking other form of therapy for the terminal illness. First opinions in cancer treatment gives the patient a confirmation of the ailment, possible treatments and ways of doing it to avoid uneccessary procedures which the second opinion can afford. An increasingly complex variety of cancers, combined with the development of oncological therapies, requires additional consultation from a physician. This segment also occupies a dominant position in the market indicating the growth of interest in expert opinions especially in severe and complicated diseases such as cancer.
By Service Providers, Physicians segment expected to held the largest share
Based on the service provider, the physicians’ segment is expected to lead the Medical Second Opinion Market. Physicians they are usually the best source of second opinion because they have knowledge and conduct direct patient care. Initial examinations from physicians are more favorable than second opinions to patients, as these second opinions are more precise and are driven by experts other than the patients’ primary doctors. Physician professionalism, specialized knowledge, credibility, and experience place them in a vantage position as far as demand by both customers and healthcare service organizations is concerned. This has contributed in refuting the earlier perception that second opinion social segment was insignificant due to lack active participation from the physicians to ensure it had a strong ground in the market showed the need for expert opinion in addressing patient decisions.
Medical Second Opinion Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
North America held the largest share in the Medical Second Opinion Market in 2023 due to favorable healthcare infrastructure, higher spending on healthcare costs and a vast population looking forward to acquiring the best Medical Second Opinion Services. The region has experienced a marked demand for second-medical-opinion services, and this is the reason why the US has a higher growth than other regions, mainly because of the well-established medical technology and strong networks of specialist physicians. Currently, North America dominates the market, contributing to 40% market share, which thereby makes it the most developed market in medical second opinions. The key factors that have contributed towards its sustenance are the high penetration of digital health platforms across countries in this region along with a very big focus on value based care.
Active Key Players in the Medical Second Opinion Market:
Apollo Hospitals (India)
AXA PPP Healthcare (UK)
Best Doctors Inc. (USA)
Cigna HealthCare (USA)
Cleveland Clinic (USA)
DoctorSpring (India)
Elite Medical Services (Germany)
Grand Rounds, Inc. (USA)
Johns Hopkins Medicine (USA)
London Medical Concierge (UK)
Mediguide (USA)
Partners Healthcare (USA)
SecondOpinions.com (USA)
Teladoc Health (USA)
WorldCare International, Inc. (USA)
Other Active Players
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Medical Second Opinion Market by Condition
4.1 Medical Second Opinion Market Snapshot and Growth Engine
4.2 Medical Second Opinion Market Overview
4.3 Cancer
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Cancer: Geographic Segmentation Analysis
4.4 Neurological Disorders
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Neurological Disorders: Geographic Segmentation Analysis
4.5 Orthopedic Disorders
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Orthopedic Disorders: Geographic Segmentation Analysis
4.6 Organ Transplant
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Organ Transplant: Geographic Segmentation Analysis
4.7 Ocular Disorders
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Ocular Disorders: Geographic Segmentation Analysis
4.8 Others
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Others: Geographic Segmentation Analysis
Chapter 5: Medical Second Opinion Market by Service Providers
5.1 Medical Second Opinion Market Snapshot and Growth Engine
5.2 Medical Second Opinion Market Overview
5.3 Physicians
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Physicians: Geographic Segmentation Analysis
5.4 Hospitals
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hospitals: Geographic Segmentation Analysis
5.5 Specialty Clinics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Specialty Clinics: Geographic Segmentation Analysis
5.6 Health Insurance Companies
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Health Insurance Companies: Geographic Segmentation Analysis
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Medical Second Opinion Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MEDIGUIDE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 JOHNS HOPKINS MEDICINE
6.4 AXA PPP HEALTHCARE
6.5 TELADOC HEALTH
6.6 CLEVELAND CLINIC
6.7 OTHER ACTIVE PLAYERS
Chapter 7: Global Medical Second Opinion Market By Region
7.1 Overview
7.2. North America Medical Second Opinion Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Condition
7.2.4.1 Cancer
7.2.4.2 Neurological Disorders
7.2.4.3 Orthopedic Disorders
7.2.4.4 Organ Transplant
7.2.4.5 Ocular Disorders
7.2.4.6 Others
7.2.5 Historic and Forecasted Market Size By Service Providers
7.2.5.1 Physicians
7.2.5.2 Hospitals
7.2.5.3 Specialty Clinics
7.2.5.4 Health Insurance Companies
7.2.5.5 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Medical Second Opinion Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Condition
7.3.4.1 Cancer
7.3.4.2 Neurological Disorders
7.3.4.3 Orthopedic Disorders
7.3.4.4 Organ Transplant
7.3.4.5 Ocular Disorders
7.3.4.6 Others
7.3.5 Historic and Forecasted Market Size By Service Providers
7.3.5.1 Physicians
7.3.5.2 Hospitals
7.3.5.3 Specialty Clinics
7.3.5.4 Health Insurance Companies
7.3.5.5 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Russia
7.3.6.2 Bulgaria
7.3.6.3 The Czech Republic
7.3.6.4 Hungary
7.3.6.5 Poland
7.3.6.6 Romania
7.3.6.7 Rest of Eastern Europe
7.4. Western Europe Medical Second Opinion Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Condition
7.4.4.1 Cancer
7.4.4.2 Neurological Disorders
7.4.4.3 Orthopedic Disorders
7.4.4.4 Organ Transplant
7.4.4.5 Ocular Disorders
7.4.4.6 Others
7.4.5 Historic and Forecasted Market Size By Service Providers
7.4.5.1 Physicians
7.4.5.2 Hospitals
7.4.5.3 Specialty Clinics
7.4.5.4 Health Insurance Companies
7.4.5.5 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 The Netherlands
7.4.6.5 Italy
7.4.6.6 Spain
7.4.6.7 Rest of Western Europe
7.5. Asia Pacific Medical Second Opinion Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Condition
7.5.4.1 Cancer
7.5.4.2 Neurological Disorders
7.5.4.3 Orthopedic Disorders
7.5.4.4 Organ Transplant
7.5.4.5 Ocular Disorders
7.5.4.6 Others
7.5.5 Historic and Forecasted Market Size By Service Providers
7.5.5.1 Physicians
7.5.5.2 Hospitals
7.5.5.3 Specialty Clinics
7.5.5.4 Health Insurance Companies
7.5.5.5 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Medical Second Opinion Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Condition
7.6.4.1 Cancer
7.6.4.2 Neurological Disorders
7.6.4.3 Orthopedic Disorders
7.6.4.4 Organ Transplant
7.6.4.5 Ocular Disorders
7.6.4.6 Others
7.6.5 Historic and Forecasted Market Size By Service Providers
7.6.5.1 Physicians
7.6.5.2 Hospitals
7.6.5.3 Specialty Clinics
7.6.5.4 Health Insurance Companies
7.6.5.5 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkiye
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Medical Second Opinion Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Condition
7.7.4.1 Cancer
7.7.4.2 Neurological Disorders
7.7.4.3 Orthopedic Disorders
7.7.4.4 Organ Transplant
7.7.4.5 Ocular Disorders
7.7.4.6 Others
7.7.5 Historic and Forecasted Market Size By Service Providers
7.7.5.1 Physicians
7.7.5.2 Hospitals
7.7.5.3 Specialty Clinics
7.7.5.4 Health Insurance Companies
7.7.5.5 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Q1: What would be the forecast period in the Medical Second Opinion Market research report?
A1: The forecast period in the Medical Second Opinion Market research report is 2024-2032.
Q2: Who are the key players in the Medical Second Opinion Market?
A2: Apollo Hospitals (India), AXA PPP Healthcare (UK), Best Doctors Inc. (USA), Cigna HealthCare (USA), Cleveland Clinic (USA), DoctorSpring (India), Elite Medical Services (Germany), Grand Rounds, Inc. (USA), Johns Hopkins Medicine (USA), London Medical Concierge (UK), Mediguide (USA), Partners Healthcare (USA), SecondOpinions.com (USA), Teladoc Health (USA), WorldCare International, Inc. (USA), and Other Active Players.
Q3: What are the segments of the Medical Second Opinion Market?
A3: The Medical Second Opinion Market is segmented into Condition, Service Providers and region. By Condition, the market is categorized into Cancer, Neurological Disorders, Orthopedic Disorders, Organ Transplant, Ocular Disorders, Others. By Service Providers, the market is categorized into Physicians, Hospitals, Specialty Clinics, Health Insurance Companies, Others. By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Russia, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Medical Second Opinion Market?
A4: The Medical Second Opinion Market as defined in this research is the industry that deals with offering consultation services beyond the initial encounters that involve referrals to healthcare professionals with expertise in diagnosis and treatment of certain conditions or diseases. They can use this market to find other opinions for a confirmed disease or treatment options, as well as obtain more information about the disease or condition in aggravated cases. Telemedicine and digital health platforms enabling the delivery of second medical opinions have grown in the global market helping patient-champions to support them in decision-making processes for their treatment.
Q5: How big is the Medical Second Opinion Market?
A5: Medical Second Opinion Market Size Was Valued at USD 6.7 Billion in 2023, and is Projected to Reach USD 26.49 Billion by 2032, Growing at a CAGR of 16.5% From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
